Spectral AI Inc. (MDAI)
NASDAQ (CM) NASDAQ (CM) Primary 
Spectral AI secures government funding to advance battlefield wound assessment device
Spectral AI Inc (NASDAQ:MDAI) announced that it has been awarded more than $850,000 from the Medical Technology Enterprise Consortium (MTEC), a biomedical group collaborating with the US Army Medical Material Development Activity, to support the ongoing development of its DeepView SnapShot M. Spectral AI's DeepView SnapShot M is a handheld predictive wound healing device targeting battlefield applications based on its AI-driven DeepView System Platform, which uses multispectral imaging trained against a database of more than 340 billion clinically validated data points to assess a burn wound's healing potential before other medical intervention.
Spectral AI completes burn center enrollment early for pivotal study
Spectral AI Inc (NASDAQ:MDAI) announced that it has completed the enrollment of adult and pediatric patients at US burn centers for its pivotal study designed to validate the AI algorithm used by its DeepView system for the burn indication. The company said the data collected from these burn center patients will be used to pursue a De Novo classification from the US Food and Drug Administration (FDA) for the use of the DeepView System in burn centers.
Spectral AI to present data from ongoing pivotal burn study at conference
Spectral AI Inc (NASDAQ:MDAI) announced that its chief medical consultant Dr Jeffrey Carter will present data from its ongoing multicenter study evaluating its DeepView System for burns at an upcoming conference. The DeepView System leverages non-invasive multispectral imaging technology and proprietary AI to detect non-healing areas of a wound following a burn injury.
Spectral AI, Inc. (MDAI) Q2 2024 Earnings Call Transcript
Spectral AI, Inc. (NASDAQ:MDAI ) Q2 2024 Results Conference Call August 12, 2024 5:00 PM ET Company Participants Devin Sullivan - Managing Director, The Equity Group, Inc. Peter Carlson - Chief Executive Officer Vince Capone - Chief Financial Officer Jeremiah Sparks - Chief Commercial Officer Conference Call Participants Ryan Zimmerman - BTIG Carl Byrnes - Northland Capital Markets RK Ramakanth - HC Wainwright John Vandermosten - Zacks Operator Good day, and welcome to the Spectral AI Inc. Second Quarter 2024 Financial Results Conference Call. All participants will be in a listen-only mode.
Spectral AI grows revenue, advances DeepView System for burns in Q2
Spectral AI Inc (NASDAQ:MDAI) reported a 76% year-over-year jump in revenue for the second quarter as it advanced its AI-driven DeepView System for the burn indication. The company said its Q2 research and development revenue was $7.5 million up from $4.3 million due to increased activity under its Project BioShield contract with BARDA for the advanced development of the DeepView System.
Spectral AI advances handheld burn assessment device for military use
Spectral AI Inc (NASDAQ:MDAI) announced it continues to advance the development of the DeepView SnapShot M, a handheld diagnostic tool for battlefield burn assessments leveraging its AI-driven DeepView System platform. The company highlighted that the DeepView SnapShot M has been designed to be part of the battlefield triage process by providing a fast and accurate assessment of burn wounds.
Spectral AI expands patent portfolio, bolstering AI-driven wound care platform
Spectral AI Inc (NASDAQ:MDAI) announced a 30% increase in its patent portfolio, enhancing the protection of its proprietary DeepView System wound assessment platform. The total number of patents granted to the company rose to 26, up from 20 at the end of the 2023 calendar year.
Spectral AI adds three new clinical sites to pivotal burn study
Spectral AI Inc (NASDAQ:MDAI) announced it has added three new US trial sites to its 2024 Burn Pivotal Study, bringing the total number of sites, including burn centers and emergency departments, to 16. The Medical Center Burn Center at Texas Tech University Health Sciences Center led by principal investigator Dr Alan Pang; Tampa General Hospital Burn Center led by principal investigator Dr Jared Troy; and the University of South Alabama Health Emergency Department led by Andrew Bright have been added to the study, the Dallas-based predictive AI company said on Tuesday.
Spectral AI highlights concerns over stock manipulation
Spectral AI Inc (NASDAQ:MDAI) has updated stakeholders on its efforts to address potential market manipulation involving its common stock, primarily through naked short selling. The AI-driven medical diagnostics company told shareholders that it is continuing to support an ongoing naked short selling inquiry led by Erich Spangenberg, a board member and the company's largest shareholder.
Spectral AI works with market leader on initial steps in Australia
Spectral AI Inc (NASDAQ:MDAI) said it will be assisted by a leading medical device company and burn wound therapy company in its application and potential deployment of its DeepView System for burn indication in Australia. Under a collaboration agreement signed between the two companies, Melbourne-based PolyNovo Ltd will help with Spectral AI's near-term goal of deploying up to two of the systems at the Royal Adelaide Hospital (pictured) and The Alfred Hospital in Melbourne.
Spectral AI adds two clinical trial sites to pivotal burn study
Spectral AI Inc (NASDAQ:MDAI) announced that it has added two US clinical trial sites to its 2024 burn study, the University of California San Diego and the University of Utah. The medical diagnostics company said the addition of these new locations expands the total number of US clinical trial sites to 14.
Spectral AI achieves full pediatric enrollment in pivotal burn study
Spectral AI Inc (NASDAQ:MDAI), a company specializing in AI-driven medical diagnostics, has announced the completion of pediatric patient enrollment for its 2024 pivotal study. The study aims to validate the AI algorithm of its DeepView System for burn indications and is set to conclude in the fourth quarter of 2024.
